Sulodexide
Sponsors
Keryx Biopharmaceuticals, University of Iowa, Corbridge Group Philippines, Inc., Ajou University School of Medicine, Bama GeVe, S.L.U.
Conditions
AnticoagulantCOVID-19Chronic Kidney DiseaseCovid19Dense Deposit DiseaseDiabetic NephropathyDiabetic Nephropathy Type 2Diabetic Retinopathy
Phase 1
Phase 2
Diabetic Retinopathy Sulodexide Study
CompletedNCT01295775
Start: 2009-02-28End: 2011-05-31Updated: 2012-11-06
Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus
CompletedNCT02737670
Start: 2014-08-31End: 2017-08-31Updated: 2017-09-14
Suloexide in the Treatment of Early Stages of COVID-19
CompletedNCT04483830
Start: 2020-06-05End: 2020-09-07Updated: 2020-09-09
Phase 3
Effect of Sulodexide in Early Diabetic Nephropathy
CompletedNCT00130208
Start: 2005-08-31End: 2008-02-29Updated: 2018-03-23
Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
TerminatedNCT00462202
Start: 2007-04-30End: 2008-03-31Updated: 2017-03-03
The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease
NCT01000545
Start: 2009-11-30End: 2012-12-31Target: 1508Updated: 2009-10-30
Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone
NCT03370705
Start: 2019-01-31End: 2020-03-30Target: 156Updated: 2019-12-02
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
RecruitingNCT04257487
Start: 2020-12-21End: 2027-01-02Target: 1455Updated: 2024-07-31
Endothelial Protection in Post COVID-19 Patients With Sulodexide
CompletedNCT05371925
Start: 2023-06-01End: 2024-04-19Updated: 2024-08-09
Sulodexide in Controlling the Recurrence of Psoriasis
Enrolling by invitationNCT06982196
Start: 2025-04-20End: 2027-12-31Target: 160Updated: 2025-05-21
Phase 4
Effect of Sulodexide in Overt Diabetic Nephropathy
TerminatedNCT00130312
Start: 2005-08-31End: 2008-03-31Updated: 2021-03-19
Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide
TerminatedNCT02512601
Start: 2015-09-30End: 2017-02-28Updated: 2017-08-31
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)
WithdrawnNCT03504566
Start: 2017-11-15End: 2019-06-01Updated: 2018-09-14
Endothelial Protection in Convalescent COVID-19 Patients
TerminatedNCT05252923
Start: 2022-04-01End: 2022-12-31Updated: 2025-06-13